AZ Groeninge

Az itteni vizsgálatok

Miről szól a helyszín 55 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Prosztatarák7 vizsgálat
• Stroke (szélütés)5 vizsgálat
• Áttétes emlőrák4 vizsgálat
• Tüdőrák4 vizsgálat
• Colitis ulcerosa3 vizsgálat
• Máj- és epeúti rák3 vizsgálat
• Vastagbélrák3 vizsgálat
• Alzheimer-kór2 vizsgálat
• Fej-nyaki daganatok2 vizsgálat
• Gyermekkori daganatok2 vizsgálat
• Mielóma multiplex2 vizsgálat
• Peripheral artery disease2 vizsgálat
• és még 24

Fázis

• 3. fázis16 vizsgálat
• 2. fázis9 vizsgálat
• 4. fázis4 vizsgálat
• 1/2. fázis2 vizsgálat
• 2/3. fázis2 vizsgálat
• 1. fázis1 vizsgálat

Állapot

• Toboroz19 vizsgálat
• Lezárult17 vizsgálat
• Fut, nem toboroz12 vizsgálat
• Még nem toboroz4 vizsgálat
• Leállították2 vizsgálat
• Meghívásos bevonás1 vizsgálat

Fő szponzor

• Janssen Research & Development, LLC5 vizsgálat
• Hoffmann-La Roche4 vizsgálat
• Universitaire Ziekenhuizen KU Leuven3 vizsgálat
• ALX Oncology Inc.2 vizsgálat
• Biogen2 vizsgálat
• és még 35

Futó vizsgálatok

• Még nem toboroz

  Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)

  NCT07782112· 3. fázis· Ente Ospedaliero Cantonale, Bellinzona· Forrás

  Contact: Aurélie De Bruycker, MD

• Még nem toboroz

  INPACT: Implementation of Nutritional Support and Physical Activity During Cancer Treatment

  NCT07929597· General Hospital Groeninge· Forrás

  Contact: Celine De Meyere

• Toboroz

  RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

  NCT07413939· 2/3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study of TAK-755 in Adults With Acute Ischemic Stroke

  NCT07392450· 2. fázis· Takeda· Forrás

  Contact: Peter Vanacker (principal investigator)

• Toboroz

  LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer

  NCT06831955· 2. fázis· Universitaire Ziekenhuizen KU Leuven· Forrás

  Contact: Marianne Hanssens, MD

• Toboroz

  The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension

  NCT07359599· 4. fázis· Ziekenhuis Oost-Limburg· Forrás

  Contact: Helena Vandenbroeke

• Toboroz

  Effect of IMT in Patients After Acute Exacerbations of COPD

  NCT07213128· KU Leuven· Forrás

  Contact: Martijn Vandebotermet

• Toboroz

  A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

  NCT07230691· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

  NCT07218146· 3. fázis· Zai Lab (Shanghai) Co., Ltd.· Forrás

• Toboroz

  Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)

  NCT06925984· Jules Bordet Institute· Forrás

  Contact: Isabelle Kindts, MD PhD

• Fut, nem toboroz

  AI for Detection of Brain Aneurysm: Low-cost Opportunistic Screening

  NCT07123818· Ziekenhuis Oost-Limburg· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  NCT06973187· 3. fázis· BeOne Medicines· Forrás

• Toboroz

  Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume

  NCT06719440· Cliniques universitaires Saint-Luc- Université Catholique de Louvain· Forrás

  Contact: Secretary office

• Toboroz

  Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

  NCT06571149· 4. fázis· Insel Gruppe AG, University Hospital Bern· Forrás

• Toboroz

  Improving the Use of Immunotherapy to Treat Liver Cancer

  NCT07623265· Universitaire Ziekenhuizen KU Leuven· Forrás

  Contact: Alexander Vanden Bulcke, MD

• Toboroz

  The Prevalence and the Pathophysiological Role of Non-Helicobacter Pylori Helicobacter Spp. in Well-defined Gastric Diseases and (Pre-) Malignancies

  NCT07770126· Universiteit Antwerpen· Forrás

  Contact: Janne Verschaete

• Toboroz

  Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.

  NCT06523634· Jules Bordet Institute· Forrás

  Contact: Nora Sundahl, MD PhD

• Toboroz

  Study on the Clinical Efficacy of Teclistamab and Talquetamab

  NCT06477783· Universitaire Ziekenhuizen KU Leuven· Forrás

• Meghívásos bevonás

  Snapshot Study on Patients With Heart Failure

  NCT06469814· European Society of Cardiology· Forrás

• Toboroz

  Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma

  NCT06691425· Cancer Research Antwerp· Forrás

  Contact: Karin Stellamans, MD, PhD (principal investigator)

• Toboroz

  The RECLAIM Study.

  NCT06450444· Salvia BioElectronics· Forrás

  Contact: Dr. Vanhee

• Toboroz

  Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

  NCT06276491· 1. fázis· Xencor, Inc.· Forrás

• Toboroz

  Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers

  NCT06282588· 2/3. fázis· Cancer Research Antwerp· Forrás

  Contact: Nick Liefhooghe

• Toboroz

  Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer

  NCT06896890· 1/2. fázis· Inhatarget Therapeutics· Forrás

  Contact: S. Derijcke

• Toboroz

  A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study

  NCT05862285· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke

  NCT05029414· University Hospital, Basel, Switzerland· Forrás

• Toboroz

  Belgian Registry on Coronary Function Testing

  NCT06089031· University Hospital, Antwerp· Forrás

  Contact: Carlos Van Mieghem, MD PhD

• Fut, nem toboroz

  Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)

  NCT04675333· 2. fázis· ALX Oncology Inc.· Forrás

• Fut, nem toboroz

  Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)

  NCT04675294· 2. fázis· ALX Oncology Inc.· Forrás

• Fut, nem toboroz

  Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

  NCT04579380· 2. fázis· Seagen, a wholly owned subsidiary of Pfizer· Forrás

• Fut, nem toboroz

  Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)

  NCT04509700· 2. fázis· Incyte Corporation· Forrás

• Fut, nem toboroz

  A Study Evaluating the Endovascular Treatment of Subjects With Stenotic or Restenotic Lesions of the Common Femoral Artery With the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy

  NCT04349657· KANDO Research· Forrás

• Fut, nem toboroz

  PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases

  NCT03569241· 2. fázis· University Hospital, Ghent· Forrás

• Fut, nem toboroz

  A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

  NCT03473743· 1/2. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer

  NCT03431350· 2. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  ASPIRIN Trial Belgium

  NCT03464305· 3. fázis· University Hospital, Antwerp· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Prosztatarák3 toboroz
• Tüdőrák3 toboroz
• Áttétes emlőrák2 toboroz
• Máj- és epeúti rák2 toboroz
• Stroke (szélütés)2 toboroz
• Glioblasztóma1 toboroz
• Gyermekkori daganatok1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Hasnyálmirigyrák1 toboroz
• Koszorúér-betegség1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)1 toboroz
• Magas vérnyomás1 toboroz
• Méhtestrák1 toboroz
• Mielóma multiplex1 toboroz
• Migrén1 toboroz
• Petefészekrák1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Szívelégtelenség1 toboroz
• Tripla negatív emlőrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA

  NCT05992142· 4. fázis· Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW· Forrás

• Leállították

  A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

  NCT05310071· 3. fázis· Biogen· Forrás

• Lezárult

  Thumb Hemi-Arthroplasty With Natural Kinematics (THANKS) Trial

  NCT05644132· Loci Orthopaedics· Forrás

• Lezárult

  Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy

  NCT04813627· BioNTech SE· Forrás

• Lezárult

  A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy

  NCT04836559· 2. fázis· Janssen Research & Development, LLC· Forrás

• Leállították

  A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

  NCT04241068· 3. fázis· Biogen· Forrás

• Lezárult

  Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

  NCT03778931· 3. fázis· Stemline Therapeutics, Inc.· Forrás

• Lezárult

  Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis

  NCT03593590· Hoffmann-La Roche· Forrás

• Lezárult

  CERENOVUS Neurothrombectomy Devices Registry

  NCT03685578· Cerenovus, Part of DePuy Synthes Products, Inc.· Forrás

• Lezárult

  DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]

  NCT03523585· 3. fázis· Daiichi Sankyo· Forrás

• Lezárult

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

  NCT03283085· 3. fázis· Shire· Forrás

• Lezárult

  A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

  NCT03301220· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Belgian Trial Investigating the LifeStream Stent in Complex TASC C and D Iliac Lesions

  NCT03349996· ID3 Medical· Forrás

• Lezárult

  Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

  NCT03072238· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

  NCT02975934· 3. fázis· pharmaand GmbH· Forrás

• Lezárult

  A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

  NCT02684006· 3. fázis· Pfizer· Forrás

• Lezárult

  Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

  NCT01938248· 4. fázis· Population Health Research Institute· Forrás

• Lezárult

  R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

  NCT01865110· 3. fázis· The Lymphoma Academic Research Organisation· Forrás